Ulrike Weirauch

851 total citations
17 papers, 700 citations indexed

About

Ulrike Weirauch is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Ulrike Weirauch has authored 17 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Ulrike Weirauch's work include RNA Interference and Gene Delivery (7 papers), MicroRNA in disease regulation (7 papers) and Cancer Mechanisms and Therapy (6 papers). Ulrike Weirauch is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), MicroRNA in disease regulation (7 papers) and Cancer Mechanisms and Therapy (6 papers). Ulrike Weirauch collaborates with scholars based in Germany, Luxembourg and Australia. Ulrike Weirauch's co-authors include Achim Aigner, Roland K. Hartmann, Arnold Grünweller, Maren Thomas, Kerstin Lange‐Grünweller, Franz Bracher, Nadine Beckmann, K. Huber, Donat Kögel and Benedikt Linder and has published in prestigious journals such as Cancer Research, Oncogene and Cancer Letters.

In The Last Decade

Ulrike Weirauch

16 papers receiving 691 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrike Weirauch Germany 12 531 404 138 106 44 17 700
Maren Thomas Germany 6 455 0.9× 370 0.9× 120 0.9× 74 0.7× 29 0.7× 6 585
Maša Alečković United States 8 326 0.6× 180 0.4× 92 0.7× 190 1.8× 89 2.0× 17 536
Timothy A. Yap United Kingdom 8 289 0.5× 111 0.3× 72 0.5× 200 1.9× 40 0.9× 10 568
Jennifer R. Devlin Australia 11 577 1.1× 120 0.3× 62 0.4× 222 2.1× 53 1.2× 16 734
GP Margison United Kingdom 16 686 1.3× 217 0.5× 56 0.4× 254 2.4× 45 1.0× 21 888
Beate Alinger Austria 19 490 0.9× 152 0.4× 79 0.6× 192 1.8× 75 1.7× 23 734
Jinsang Yoo South Korea 13 367 0.7× 145 0.4× 88 0.6× 167 1.6× 60 1.4× 16 549
Alice Cani Italy 14 394 0.7× 121 0.3× 80 0.6× 126 1.2× 63 1.4× 26 645
Shaokun Shu United States 11 330 0.6× 167 0.4× 64 0.5× 208 2.0× 108 2.5× 18 575

Countries citing papers authored by Ulrike Weirauch

Since Specialization
Citations

This map shows the geographic impact of Ulrike Weirauch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Weirauch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Weirauch more than expected).

Fields of papers citing papers by Ulrike Weirauch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Weirauch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Weirauch. The network helps show where Ulrike Weirauch may publish in the future.

Co-authorship network of co-authors of Ulrike Weirauch

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Weirauch. A scholar is included among the top collaborators of Ulrike Weirauch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Weirauch. Ulrike Weirauch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Reiche, Kristin, Ulrike Weirauch, Markus Kreuz, et al.. (2025). Virtual twins for personalised CAR T-cell therapy in myeloma. The Lancet Haematology. 12(7). e490–e491.
2.
Linder, Benedikt, Ulrike Weirauch, Bryan W. Day, et al.. (2022). STAT3 Enhances Sensitivity of Glioblastoma to Drug-Induced Autophagy-Dependent Cell Death. Cancers. 14(2). 339–339. 10 indexed citations
3.
4.
5.
Büch, Thomas, Nicole Urban, Ulrike Weirauch, et al.. (2020). Restoration of MARCK enhances chemosensitivity in cancer. Journal of Cancer Research and Clinical Oncology. 146(4). 843–858. 12 indexed citations
6.
Kunz, Manfred, Animesh Bhattacharya, Alexander Ewe, et al.. (2020). Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma. Journal of Nanobiotechnology. 18(1). 22 indexed citations
7.
Linder, Benedikt, Ulrike Weirauch, Alexander Ewe, et al.. (2019). Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model. Cancers. 11(3). 333–333. 26 indexed citations
8.
Hartmann, Roland K., et al.. (2019). Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in�vitro and in�vivo primarily through the modulation of cell cycle progression. International Journal of Oncology. 56(2). 448–459. 13 indexed citations
9.
Linder, Benedikt, Ulrike Weirauch, Julia Konovalova, et al.. (2018). Inhibition of PIM1 blocks the autophagic flux to sensitize glioblastoma cells to ABT-737-induced apoptosis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1866(2). 175–189. 18 indexed citations
10.
Weirauch, Ulrike, Arnold Grünweller, Luis E. Cuéllar, Roland K. Hartmann, & Achim Aigner. (2013). U1 Adaptors for the Therapeutic Knockdown of the Oncogene Pim-1 Kinase in Glioblastoma. Nucleic Acid Therapeutics. 23(4). 264–272. 7 indexed citations
11.
Weirauch, Ulrike, et al.. (2013). Polymer-Based Delivery of RNA-Based Therapeutics in Ovarian Cancer. Methods in molecular biology. 1049. 443–465. 2 indexed citations
12.
Weirauch, Ulrike, Nadine Beckmann, Maren Thomas, et al.. (2013). Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma. Neoplasia. 15(7). 783–IN28. 85 indexed citations
13.
Weirauch, Ulrike, Nadine Beckmann, Maren Thomas, et al.. (2013). Functional Role and Therapeutic Potential of the Pim-1 Kinase in Colon Carcinoma. Neoplasia. 15(7). 773–IN27. 21 indexed citations
14.
Thomas, Maren, Kerstin Lange‐Grünweller, Udo Bakowsky, et al.. (2012). PEI-complexed LNA antiseeds as miRNA inhibitors. RNA Biology. 9(8). 1088–1098. 18 indexed citations
15.
Weirauch, Ulrike, et al.. (2011). MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma. Cancer Research. 71(15). 5214–5224. 331 indexed citations
16.
Thomas, Maren, Kerstin Lange‐Grünweller, Ulrike Weirauch, et al.. (2011). The proto-oncogene Pim-1 is a target of miR-33a. Oncogene. 31(7). 918–928. 100 indexed citations
17.
Mescalchin, Alessandra, et al.. (2010). Antisense tools for functional studies of human Argonaute proteins. RNA. 16(12). 2529–2536. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maren Thomas Breakdown of academic impact, for papers by Maša Alečković Breakdown of academic impact, for papers by Timothy A. Yap Breakdown of academic impact, for papers by Jennifer R. Devlin Breakdown of academic impact, for papers by GP Margison Breakdown of academic impact, for papers by Beate Alinger Breakdown of academic impact, for papers by Jinsang Yoo Breakdown of academic impact, for papers by Alice Cani Breakdown of academic impact, for papers by Shaokun Shu
Rankless by CCL
2026